Return to search results
Metoprolol tartrate
Lopressor is a prescription oral solution containing metoprolol tartrate at 10 mg/mL. It's a beta-blocker medication used to treat high blood pressure, chest pain, and heart failure by slowing heart rate and reducing blood pressure. Manufactured by Validus Pharmaceuticals LLC, it was approved under NDA219373 and is set for market release in April 2025. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lopressor is a prescription oral solution containing metoprolol tartrate at 10 mg/mL. It's a beta-blocker medication used to treat high blood pressure, chest pain, and heart failure by slowing heart rate and reducing blood pressure. Manufactured by Validus Pharmaceuticals LLC, it was approved under NDA219373 and is set for market release in April 2025. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Metoprolol tartrate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Metoprolol tartrate — ANDA 076792 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076792"
}
]
|
| identifier | ANDA076792 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"fda",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Metoprolol tartrate |
